Profounda Health & Beauty

Profounda is a specialty pharmaceutical company headquartered in Orlando, Florida, dedicated to providing high-quality healthcare products in niche therapeutic areas. The company's portfolio includes both prescription drugs and over-the-counter (OTC) consumer products, with a significant focus on rhinology and rare infectious diseases. Profounda is notably the US distributor for Impavido (miltefosine), an orphan drug used for the treatment of leishmaniasis and the rare, often fatal brain-eating amoeba infection, Primary Amebic Meningoencephalitis (PAM). Additionally, the company markets the Rhinase line of nasal care products designed to alleviate nasal dryness and irritation. Through strategic licensing and acquisitions, Profounda aims to address unmet medical needs in specialized patient populations.